Page last updated: 2024-10-29

iohexol and Hepatocellular Carcinoma

iohexol has been researched along with Hepatocellular Carcinoma in 85 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)."9.16Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012)
"The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma."7.72Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003)
"The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively."7.69Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995)
"To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)."5.16Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012)
"To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging."3.79Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013)
"The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma."3.72Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003)
"9 months) in 52 patients with hepatocellular carcinoma (HCC): An emulsion of Lipiodol and epirubicin was injected as selectively as possible in a dosage proportional to liver function and tumour size."3.69[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy]. ( Brambs, HJ; Claussen, CD; Dette, S; Dietz, K; Duda, SH; Geissler, F; Huppert, PE; Lauchart, W, 1994)
"The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively."3.69Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995)
"In contrast, among patients with hepatocellular carcinoma, mean contrast enhancement in lesions in the arterial phase was significantly superior in group A compared with group B."2.69Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. ( Balzer, J; Clauss, W; Felfe, R; Felix, R; Hänninen, EL; Pegios, W; Vogl, TJ, 2000)
"Pathology confirmed hepatocellular carcinoma (HCC) in 3 atypical nodules and FNH-like histology in 3 atypical and 4 typical nodules."1.46Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. ( Fidler, JL; Hough, DM; Kamath, PS; Poterucha, JT; Venkatesh, SK; Wells, ML, 2017)
"DECT was applied in 46 patients with hepatocellular carcinoma (HCC) prior to RE."1.42Impact of dual-energy CT prior to radioembolization (RE). ( Altenbernd, JC; Forsting, M; Heusner, T; Lauenstein, T; Nagarajah, J; Ringelstein, A; Theysohn, JM; Umutlu, L; von der Stein, I; Wetter, A, 2015)
"Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning."1.40Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. ( Choi, SJ; Kim, HS; Kim, J; Lee, JM; Park, H; Seo, J, 2014)
"Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have a hypovascular pattern on computed tomography (CT)."1.38Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. ( Chung, GE; Jang, JJ; Kim, SH; Kim, YJ; Lee, HS; Lee, JH; Lee, JM; Lee, K; Myung, SJ; Suh, KS; Yoon, JH, 2012)
"Twenty-four hepatocellular carcinomas were targeted in 18 patients (14 men, four women; mean age, 66 years), and segmental or lobar chemoembolization with intraprocedural transcatheter intraarterial perfusion MRI was successful in all 18."1.38Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI. ( Gaba, RC; Jin, B; Larson, AC; Lewandowski, RJ; Omary, RA; Ragin, AB; Salem, R; Wang, D, 2012)
"Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis."1.37Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011)
"To describe imaging findings of early hepatocellular carcinoma (HCC) at gadoxetic acid-enhanced magnetic resonance (MR) imaging, dynamic contrast material-enhanced computed tomography (CT), CT during arterial portography (CTAP), and CT during hepatic arteriography (CTHA) and to compare the diagnostic performance of each modality for small (≤ 2 cm) HCC."1.37Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. ( Araki, T; Asakawa, M; Enomoto, N; Fujii, H; Ichikawa, T; Kitamura, T; Matsuda, M; Motosugi, U; Muhi, AM; Nakano, M; Nakazawa, T; Sakamoto, M; Sano, K; Sou, H, 2011)
"In 20 patients with hepatocellular carcinomas, multiphasic liver CT scans including arterial, portal, and equilibrium phases were performed."1.36Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies. ( Cho, SH; Choi, BI; Han, JK; Kim, KS; Kim, KW; Kim, SH; Kim, SJ; Lee, JM, 2010)
"Fifteen patients with either hepatocellular carcinoma (HCC, n = 8) or hypervascular liver metastases from uveal melanoma (n = 7) underwent arterial and portal venous C-arm CT of the liver using intraarterial contrast media administration directly before TACE."1.35Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT. ( Borchert, M; Frericks, BB; Justiz, J; Martus, P; Meyer, BC; Voges, M; Wacker, FK; Wolf, KJ, 2008)
"To investigate the risk factors for local tumor progression after radiofrequency (RF) ablation combined with chemoembolization for the treatment of hepatocellular carcinoma (HCC)."1.34Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. ( Fuke, H; Murata, K; Nakatsuka, A; Shiraki, K; Takaki, H; Takeda, K; Yamakado, K, 2007)
"We applied it for a case of hepatocellular carcinoma with good result."1.28[Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium]. ( Hirayama, R; Ichikawa, W; Kawachi, Y; Mishima, Y; Nihei, Z; Sawai, S; Tamaru, H; Uetake, H; Yamashita, T, 1992)

Research

Studies (85)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's12 (14.12)18.2507
2000's24 (28.24)29.6817
2010's48 (56.47)24.3611
2020's1 (1.18)2.80

Authors

AuthorsStudies
Hu, HT1
Shan, QY1
Chen, SL1
Li, B1
Feng, ST1
Xu, EJ1
Li, X1
Long, JY1
Xie, XY1
Lu, MD1
Kuang, M1
Shen, JX1
Wang, W1
Jia, GS1
Feng, GL1
Li, JP1
Xu, HL1
Wang, H2
Cheng, YP1
Yan, LL1
Jiang, HJ1
Wells, ML1
Hough, DM1
Fidler, JL1
Kamath, PS1
Poterucha, JT1
Venkatesh, SK1
Sun, W1
Ding, XY1
Chen, JL1
Li, WD1
Wang, XY1
Guo, XD1
Shen, YJ1
Sun, SS1
Lin, EY1
Lee, RC1
Guo, WY1
Wu, FC1
Gehrisch, S1
Kowarschik, M1
Zhang, L1
Wang, N1
Mao, J1
Liu, X1
Gao, Z1
Dai, X1
Feng, B1
Nakano, MM1
Yamamoto, A1
Nishida, N1
Hamuro, M1
Hamamoto, S1
Jogo, A1
Sohgawa, E1
Kageyama, K1
Minami, T1
Miki, Y1
Woo, S2
Lee, JM5
Yoon, JH4
Joo, I1
Kim, SH4
Lee, JY1
Kim, YJ3
Han, JK3
Choi, BI3
Chung, JW3
Hur, S2
Joo, SM1
Kim, HC2
Jae, HJ2
Park, JH2
Yu, MH1
Baek, JH1
Flohr, TG1
Ichikawa, T5
Motosugi, U2
Morisaka, H1
Sano, K2
Ali, M1
Araki, T2
Okada, M2
Kondo, H3
Sou, H3
Murakami, T2
Kanematsu, M4
Yoshikawa, S3
Shiosakai, K2
Hayakawa, A2
Awai, K3
Yoshimitsu, K2
Yamashita, Y4
Quaia, E1
De Paoli, L1
Angileri, R1
Pizzolato, R1
Cabibbo, B1
Cova, MA1
Kim, KA1
Kim, MJ3
Choi, JY1
Park, MS2
Lim, JS1
Chung, YE1
Kim, KW2
Choi, SJ1
Kim, J2
Seo, J1
Kim, HS1
Park, H1
Tan, B1
Zhao, B1
Gong, G1
Xu, Z1
Burgmans, MC1
van Erkel, AR1
Too, CW1
Coenraad, M1
Lo, RH1
Tan, BS1
Hoffmann, R1
Rempp, H1
Syha, R1
Ketelsen, D1
Pereira, PL2
Claussen, CD3
Clasen, S1
Altenbernd, JC1
von der Stein, I1
Wetter, A1
Nagarajah, J1
Umutlu, L1
Heusner, T1
Theysohn, JM1
Ringelstein, A1
Forsting, M1
Lauenstein, T1
Kaufmann, S2
Schulze, M2
Spira, D1
Horger, M2
Chung, BM1
Park, HJ1
Park, SB1
Lee, JB1
Ahn, HS1
Kim, YS5
Lewin, M2
Gelu-Simeon, M1
Ostos, M1
Boufassa, F1
Sobesky, R1
Teicher, E1
Meyer, L1
Fontaine, H1
Salmon-Céron, D1
Samuel, D1
Seror, O1
Trinchet, JC1
Duclos-Vallée, JC1
Horger, T1
Oelker, A1
Nikolaou, K1
Duan, F1
Wang, EQ1
Lam, MG1
Abdelmaksoud, MH1
Louie, JD1
Hwang, GL1
Kothary, N1
Kuo, WT1
Hofmann, LV1
Sze, DY1
Iwai, S1
Okano, S1
Chikazawa, S1
Kakizaki, T1
Sakonju, I1
Solomon, JA1
Liu, QY1
He, CD1
Zhou, Y2
Huang, D1
Lin, H1
Wang, Z1
Wang, D3
Wang, JQ1
Liao, LP1
Ehman, EC1
Behr, SC1
Umetsu, SE1
Fidelman, N1
Yeh, BM1
Ferrell, LD1
Hope, TA1
Zhao, YJ1
Chen, WX1
Wu, DS1
Zhang, WY1
Zheng, LR1
Li, R1
Cai, P1
Ma, KS1
Ding, SY1
Guo, DY1
Yan, XC1
He, L1
Huang, Y1
Chen, S1
Wu, P1
Ye, W1
Liu, Z1
Liang, C1
Choi, JW1
Lee, JH2
Yu, SJ1
Cho, EJ1
Kim, MU1
Lee, M1
Kim, EY1
Choi, D5
Lim, DH1
Lee, WJ2
Yoo, BC1
Paik, SW1
Chen, G1
Ma, DQ1
He, W1
Zhang, BF1
Zhao, LQ1
Kubas, A1
Chapet, O1
Merle, P1
Lorchel, F1
d'Hombres, A1
Mornex, F1
Balci, NC1
Befeler, AS1
Bieneman, BK1
Fattahi, R1
Saglam, S1
Havlioglu, N1
Matoba, M1
Kitadate, M1
Kondou, T1
Yokota, H1
Tonami, H1
Park, Y1
Rhim, H4
Lim, HK4
Choi, JI1
Choi, HJ1
Jung, DC1
Hong, EK1
Park, JW1
Jang, YJ1
Kim, CM1
Kim, KS1
Kim, SJ1
Cho, SH1
Nakai, M2
Sato, M2
Ikoma, A2
Nakata, K2
Sahara, S2
Takasaka, I1
Minamiguchi, H2
Kawai, N2
Sonomura, T2
Kishi, K1
Kim, JH1
Yoon, HK1
Ko, GY1
Gwon, DI1
Jang, CS1
Song, HY1
Shin, JH1
Sung, KB1
Kim, JE1
Lee, MW3
Shin, SW1
Cho, SK1
Chung, GE1
Myung, SJ1
Lee, K1
Jang, JJ1
Suh, KS1
Lee, HS1
Cho, HS1
Seo, JW1
Kang, Y1
Bae, EJ1
Kim, HJ1
Chang, SH1
Park, DJ1
Yuan, Z1
Ye, XD1
Dong, S1
Xu, LC1
Xiao, XS1
Muhi, AM1
Matsuda, M1
Nakano, M1
Sakamoto, M1
Nakazawa, T1
Asakawa, M1
Fujii, H1
Kitamura, T1
Enomoto, N1
Tanaka, T1
Sanda, H1
Shirai, S1
Gaba, RC1
Jin, B1
Lewandowski, RJ2
Ragin, AB1
Larson, AC2
Salem, R2
Omary, RA2
Cha, DI1
Chung, WS1
Lee, KH1
Lee, YJ1
Kwon, J1
Baek, SE1
Bova, V1
Miraglia, R1
Maruzzelli, L1
Vizzini, GB1
Luca, A1
Lee, HY1
Park, MJ1
Kim, YK1
Choi, YA1
Kim, CK1
Park, BK1
Kim, B1
Lee, JA1
Jeong, WK1
Kim, Y1
Song, SY2
Heo, JN1
Park, CK1
Liu, YI1
Shin, LK1
Jeffrey, RB1
Kamaya, A1
Hayashi, M1
Matsui, O1
Ueda, K1
Kawamori, Y1
Gabata, T1
Kadoya, M1
Arrivé, L1
Rosmorduc, O1
Dahan, H1
Fartoux, L1
Monnier-Cholley, L1
Poupon, R1
Tubiana, JM1
Lin, J1
Zhou, KR1
Chen, ZW1
Wang, JH1
Yan, ZP1
Wang, YX1
Inoue, M1
Yagyu, Y1
Watanabe, M1
Sano, T1
Nin, S1
Koike, R1
Nishimura, Y1
Lu, DS2
Yu, NC1
Raman, SS1
Limanond, P1
Lassman, C1
Murray, K1
Tong, MJ1
Amado, RG1
Busuttil, RW1
Yoshikawa, T1
Ohno, Y1
Motohara, T1
Mitchell, DG1
Sugimoto, K1
Matsumoto, S1
Hirota, S1
Sugimura, K1
Lim, HG1
Goshima, S1
Yokoyama, R1
Miyoshi, T1
Nishibori, H1
Kato, H1
Hoshi, H1
Onozuka, M1
Moriyama, N1
Yenarkarn, P1
Thoeni, RF1
Hanks, D1
Takaki, H1
Yamakado, K1
Nakatsuka, A1
Fuke, H1
Murata, K1
Shiraki, K1
Takeda, K1
Tatsugami, F1
Matsuki, M1
Nakai, G1
Tanikake, M1
Narabayashi, I1
Miyaji, K1
Asai, A1
Fujiwara, S1
Hongo, Y1
Katsu, K1
Graham, JM1
Atassi, B1
Sato, KT1
Ryu, RK1
Nemcek, AA1
Mulcahy, MF1
Kulik, LM1
Miller, FH1
Meyer, BC1
Frericks, BB1
Voges, M1
Borchert, M1
Martus, P1
Justiz, J1
Wolf, KJ1
Wacker, FK1
Huppert, PE1
Geissler, F1
Duda, SH1
Lauchart, W1
Dette, S1
Dietz, K1
Brambs, HJ1
Ohtomo, K1
Takahashi, S1
Ohashi, I1
Ina, H1
Okada, Y1
Yoshida, T1
Gomi, N1
Himeno, Y1
Hanafusa, K1
Shibuya, H1
Arakawa, A1
Nishiharu, T1
Matsukawa, T1
Urata, J1
Hatanaka, Y1
Takahashi, M1
Kanemitsu, K1
Mihara, M1
Lee, HM1
Krasny, RM1
Busuttil, R1
Kadell, B1
Lucas, J1
Pacella, CM1
Bizzarri, G1
Anelli, V1
Valle, D1
Fabbrini, R1
Bianchini, A1
Fenderico, P1
Rossi, Z1
Ohgiya, Y1
Gokan, T1
Munechika, H1
Luboldt, W1
Straub, J1
Seemann, M1
Helmberger, T1
Reiser, M1
Kopka, L1
Grabbe, E1
Hänninen, EL1
Vogl, TJ1
Felfe, R1
Pegios, W1
Balzer, J1
Clauss, W1
Felix, R1
Mehnert, F1
Trübenbach, J1
Kopp, AF1
Moteki, T1
Horikoshi, H1
Oya, N1
Aoki, J1
Endo, K1
Ichikawa, W1
Nihei, Z1
Sawai, S1
Yamashita, T1
Uetake, H1
Kawachi, Y1
Hirayama, R1
Mishima, Y1
Tamaru, H1
Berde, CB1
Sethna, NF1
Fisher, DE1
Kahn, CH1
Chandler, P1
Grier, HE1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Artificial Intelligent Prognostic Assessment and Pathological Basis Research of Early Primary Hepatocellular Carcinoma After Minimally Invasive Treatment Based on Multimodal MRI and Clinical Big Data[NCT04299919]1,200 participants (Anticipated)Observational2007-04-01Active, not recruiting
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation: a Multi-center Prospective Case-control Study[NCT02046356]139 participants (Actual)Observational [Patient Registry]2014-01-31Active, not recruiting
Low Dose Multi-arterial Phase CT Imaging for Improved Detection of Liver Tumors and Pancreatic Masses[NCT04813432]50 participants (Actual)Observational2018-09-10Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for iohexol and Hepatocellular Carcinoma

ArticleYear
CT findings of primary clear cell carcinoma of liver: with analysis of 19 cases and review of the literature.
    Abdominal imaging, 2014, Volume: 39, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Ioh

2014

Trials

8 trials available for iohexol and Hepatocellular Carcinoma

ArticleYear
Volumetric low-tube-voltage CT imaging for evaluating hypervascular hepatocellular carcinoma; effects on radiation exposure, image quality, and diagnostic performance.
    Japanese journal of radiology, 2013, Volume: 31, Issue:8

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neoplasms; Ma

2013
Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: an early predictor of final treatment response.
    European journal of radiology, 2009, Volume: 72, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol;

2009
Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Hepatocellular; Chi-Square Distribu

2009
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
    Cardiovascular and interventional radiology, 2012, Volume: 35, Issue:6

    Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hep

2012
Gadolinium-enhanced phase-contrast magnetic resonance portography.
    Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2005, Dec-31, Volume: 4, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Female; Gadolinium DTP

2005
MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    AJR. American journal of roentgenology, 2006, Volume: 187, Issue:1

    Topics: Aged; Aged, 80 and over; Aortography; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatic Art

2006
Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
    Radiology, 2000, Volume: 216, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Hepatocellular; Contrast Media; Double-Blind Metho

2000
Biphasic spiral CT of the liver: automatic bolus tracking or time delay?
    European radiology, 2001, Volume: 11, Issue:3

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Processing, Computer-A

2001

Other Studies

76 other studies available for iohexol and Hepatocellular Carcinoma

ArticleYear
CT-based radiomics for preoperative prediction of early recurrent hepatocellular carcinoma: technical reproducibility of acquisition and scanners.
    La Radiologia medica, 2020, Volume: 125, Issue:8

    Topics: Adult; Aged; Algorithms; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepat

2020
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2017, Volume: 16, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Hepatocellular; Case-Control Studies; C

2017
Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
    Abdominal radiology (New York), 2017, Volume: 42, Issue:11

    Topics: Adolescent; Adult; Carcinoma, Hepatocellular; Child; Contrast Media; Diagnosis, Differential; Female

2017
[The combination of percutaneous iohexol-ethanol injection with radiofrequency ablation for the treatment of primary liver cancer in high-risk locations].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2017, Sep-23, Volume: 39, Issue:9

    Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Ther

2017
Three-Dimensional Quantitative Color-Coding Analysis of Hepatic Arterial Flow Change during Chemoembolization of Hepatocellular Carcinoma.
    Journal of vascular and interventional radiology : JVIR, 2018, Volume: 29, Issue:10

    Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Blood Flow Velocity; Carcino

2018
Dual-Energy CT-Derived Volumetric Iodine Concentration for the Assessment of Therapeutic Response after Microwave Ablation in a Rabbit Model with Intrahepatic VX2 Tumor.
    Journal of vascular and interventional radiology : JVIR, 2018, Volume: 29, Issue:10

    Topics: Ablation Techniques; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Iohexol;

2018
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
    Japanese journal of radiology, 2019, Volume: 37, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carci

2019
Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Radiology, 2013, Volume: 268, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female

2013
Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors.
    AJR. American journal of roentgenology, 2013, Volume: 200, Issue:6

    Topics: Adult; Aged; Anastomosis, Surgical; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contr

2013
Low tube voltage intermediate tube current liver MDCT: sinogram-affirmed iterative reconstruction algorithm for detection of hypervascular hepatocellular carcinoma.
    AJR. American journal of roentgenology, 2013, Volume: 201, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Carcinoma, Hepatocellular; Contras

2013
Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Academic radiology, 2013, Volume: 20, Issue:9

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Dose-Response Relationship, Drug; Female; Hospitals

2013
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Abdominal imaging, 2013, Volume: 38, Issue:6

    Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im

2013
Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
    Abdominal imaging, 2014, Volume: 39, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Liver Neo

2014
Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Abdominal imaging, 2014, Volume: 39, Issue:3

    Topics: Aged; Area Under Curve; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic

2014
Pilot study evaluating catheter-directed contrast-enhanced ultrasound compared to catheter-directed computed tomography arteriography as adjuncts to digital subtraction angiography to guide transarterial chemoembolization.
    Clinical radiology, 2014, Volume: 69, Issue:10

    Topics: Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Catheters; Chemoembolization, The

2014
Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    European journal of radiology, 2014, Volume: 83, Issue:10

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization,

2014
[Multicenter trial for optimization of bolus tracking settings and contrast material injection protocol in arterial dominant phase of dynamic computed tomography for diagnosis of hepatocellular carcinoma].
    Nihon Hoshasen Gijutsu Gakkai zasshi, 2014, Volume: 70, Issue:8

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatic Artery; Humans; Injections, Intra-A

2014
Impact of dual-energy CT prior to radioembolization (RE).
    Acta radiologica (Stockholm, Sweden : 1987), 2015, Volume: 56, Issue:11

    Topics: Aged; Angiography; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Contrast Media; Embo

2015
Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Acta radiologica (Stockholm, Sweden : 1987), 2016, Volume: 57, Issue:1

    Topics: Aged; Aged, 80 and over; Blood Volume; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Co

2016
Differentiation of small arterial enhancing hepatocellular carcinoma from non-tumorous arterioportal shunt with an emphasis on the precontrast CT scan.
    Abdominal imaging, 2015, Volume: 40, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential;

2015
Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
    Radiology, 2015, Volume: 277, Issue:2

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Coinfection; Contrast Media; Diagnostic Imaging; Female; Fra

2015
Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.
    Academic radiology, 2015, Volume: 22, Issue:9

    Topics: Adult; Aged; Blood Volume; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast Media;

2015
Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
    Radiology, 2016, Volume: 278, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Chemoem

2016
Transcatheter arterial embolization for treatment of hepatocellular carcinoma in a cat.
    Journal of the American Veterinary Medical Association, 2015, Dec-01, Volume: 247, Issue:11

    Topics: Animals; Carcinoma, Hepatocellular; Cat Diseases; Cats; Chemoembolization, Therapeutic; Contrast Med

2015
Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
    World journal of gastroenterology, 2016, Mar-21, Volume: 22, Issue:11

    Topics: Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Chemoembolization, Therape

2016
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
    Abdominal radiology (New York), 2016, Volume: 41, Issue:5

    Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Hepatectomy; Humans; Iohexol; Liver Neoplasms; Li

2016
Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Abdominal radiology (New York), 2016, Volume: 41, Issue:5

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contra

2016
Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
    Scientific reports, 2016, 05-26, Volume: 6

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagn

2016
CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Abdominal radiology (New York), 2017, Volume: 42, Issue:6

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatectomy; Huma

2017
Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
    Journal of vascular and interventional radiology : JVIR, 2017, Volume: 28, Issue:6

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Computed Tomography; Contrast M

2017
Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    World journal of gastroenterology, 2008, Oct-07, Volume: 14, Issue:37

    Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Blood Volume; Carcinoma, Hepatocel

2008
[Dosimetric impact of breath-hold in the treatment of hepatocellular carcinoma by conformal radiation therapy].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2009, Volume: 13, Issue:1

    Topics: Carcinoma, Hepatocellular; Contrast Media; Duodenum; Exhalation; France; Humans; Inhalation; Iohexol

2009
Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.
    Academic radiology, 2009, Volume: 16, Issue:8

    Topics: Adipose Tissue; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Hum

2009
Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:3

    Topics: Aged; Arteries; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Disease Progression; F

2009
Diagnostic value of early-phase-enhanced computed tomography for the differentiation of pulmonary metastases from hepatocellular carcinoma and primary lung cancer.
    Acta radiologica (Stockholm, Sweden : 1987), 2009, Volume: 50, Issue:9

    Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female;

2009
Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.
    Investigative radiology, 2010, Volume: 45, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexo

2010
Triple-phase computed tomography during arterial portography with bolus tracking for hepatic tumors.
    Japanese journal of radiology, 2010, Volume: 28, Issue:2

    Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Digestive System Neoplasms; Female; Hepatitis C; Hu

2010
Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Radiology, 2010, Volume: 255, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Cisplati

2010
Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    European journal of radiology, 2011, Volume: 79, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Hepatocellular; Catheter Ablation; Contra

2011
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
    Abdominal imaging, 2012, Volume: 37, Issue:3

    Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Female; Human

2012
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:5

    Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media

2011
Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Journal of vascular and interventional radiology : JVIR, 2011, Volume: 22, Issue:8

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Ethiodized O

2011
Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Radiology, 2011, Volume: 261, Issue:3

    Topics: Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Early Diagnosis; Female; G

2011
Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
    AJR. American journal of roentgenology, 2012, Volume: 198, Issue:5

    Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Cisplatin; Contras

2012
Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    AJR. American journal of roentgenology, 2012, Volume: 198, Issue:6

    Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Image Enhancement; Ima

2012
Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
    AJR. American journal of roentgenology, 2012, Volume: 199, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic;

2012
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
    Cardiovascular and interventional radiology, 2013, Volume: 36, Issue:2

    Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast

2013
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.
    European radiology, 2013, Volume: 23, Issue:1

    Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Case-Control Studies; Catheter Ablation; Contrast Media; Di

2013
Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
    Radiology, 2013, Volume: 266, Issue:2

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Contrast Med

2013
Dual-energy CT to detect recurrent HCC after TACE: initial experience of color-coded iodine CT imaging.
    European journal of radiology, 2013, Volume: 82, Issue:4

    Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media;

2013
Quantitatively defining washout in hepatocellular carcinoma.
    AJR. American journal of roentgenology, 2013, Volume: 200, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neopla

2013
Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.
    Radiology, 2002, Volume: 225, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Hepatic Artery;

2002
Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.
    AJR. American journal of roentgenology, 2003, Volume: 180, Issue:1

    Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluo

2003
3D contrast-enhanced MR portography and direct X-ray portography: a correlation study.
    European radiology, 2003, Volume: 13, Issue:6

    Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Hypertension, Por

2003
Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Radiology, 2004, Volume: 233, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aortography; Body Weight; Carcinoma, Hepatocellular; Contrast Media;

2004
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
    Radiology, 2005, Volume: 234, Issue:3

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Iohexol;

2005
Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients.
    Journal of vascular and interventional radiology : JVIR, 2006, Volume: 17, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Carcinoma, Hepatocell

2006
Case 107: lymphoma of the mesentery.
    Radiology, 2007, Volume: 242, Issue:2

    Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Diatrizoate Meglumine; Hepatitis

2007
Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
    Journal of vascular and interventional radiology : JVIR, 2007, Volume: 18, Issue:7

    Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modalit

2007
Hepatic computed tomography for simultaneous depiction of hepatocellular carcinoma, intrahepatic portal veins, and hepatic veins in real-time virtual sonography: initial experience.
    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2007, Volume: 26, Issue:8

    Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Hepat

2007
Isolation of peroxisomes from tissues and cells by differential and density gradient centrifugation.
    Current protocols in cell biology, 2001, Volume: Chapter 3

    Topics: Animals; Biomarkers; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line, Tumor; Centrifugation

2001
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
    Radiology, 2008, Volume: 246, Issue:3

    Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Contrast Media; Doxorubi

2008
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT.
    AJR. American journal of roentgenology, 2008, Volume: 190, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Diagnosis, D

2008
[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1994, Volume: 160, Issue:5

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Protocols; Contrast

1994
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
    Journal of gastroenterology, 1995, Volume: 30, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterizat

1995
Hepatocellular carcinoma: detection with double-phase helical CT during arterial portography.
    Radiology, 1996, Volume: 198, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver Neoplasms; Ma

1996
Segmental anatomy of the liver under the right diaphragmatic dome: evaluation with axial CT.
    Radiology, 1996, Volume: 200, Issue:3

    Topics: Angiography; Carcinoma, Hepatocellular; Contrast Media; Diaphragm; Embolization, Therapeutic; Hepati

1996
Detection of hepatocellular carcinoma by intraarterially enhanced ultrasonography with CO2 microbubbles. Comparison with DSA, dynamic CT, and Lipiodol CT.
    Acta radiologica (Stockholm, Sweden : 1987), 1996, Volume: 37, Issue:3 Pt 1

    Topics: Angiography, Digital Subtraction; Carbon Dioxide; Carcinoma, Hepatocellular; Chemoembolization, Ther

1996
Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT.
    AJR. American journal of roentgenology, 1997, Volume: 169, Issue:1

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Cirrho

1997
Evaluation of the vascular pattern of hepatocellular carcinoma with dynamic computed tomography and its use in identifying optimal temporal windows for helical computed tomography.
    European radiology, 1998, Volume: 8, Issue:1

    Topics: Aged; Aorta, Abdominal; Carcinoma, Hepatocellular; Contrast Media; Evaluation Studies as Topic; Fema

1998
Demonstration of aberrant hepatic and gastric arteries with helical CT.
    Investigative radiology, 1999, Volume: 34, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Celiac Artery; Contrast Medi

1999
Effective contrast use in CT angiography and dual-phase hepatic CT performed with a subsecond scanner.
    Investigative radiology, 1999, Volume: 34, Issue:12

    Topics: Angiography; Carcinoma, Hepatocellular; Contrast Media; Female; Hemangioma; Humans; Injections, Intr

1999
[Biphasic liver diagnosis with multiplanar-detector spiral CT].
    Der Radiologe, 1999, Volume: 39, Issue:11

    Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neoplasms; M

1999
Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images.
    Journal of magnetic resonance imaging : JMRI, 2002, Volume: 15, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential;

2002
[Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl

    Topics: Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Therapy, Combination; Emulsions; Humans

1992
Celiac plexus blockade for a 3-year-old boy with hepatoblastoma and refractory pain.
    Pediatrics, 1990, Volume: 86, Issue:5

    Topics: Bupivacaine; Carcinoma, Hepatocellular; Celiac Plexus; Child, Preschool; Ethanol; Humans; Iohexol; L

1990